Bendamustine: a new therapeutic option for hematologic malignancies.
Cheson
Bruce D
BD
Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC 20057, USA.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride